We conducted a pilot trial
using palmitoylethanolamide in a animal model for central neuropathic pain, the cavalier KIng Charles spaniel, suffering from Arnold Chiari malformations and syringomyelia, and exposing classical pain behaviour.
Not exact matches
I have read a lot of positive reviews on the
use of a dietary supplement containing
Palmitoylethanolamide, also known as PEA.
[10] Re G, Barbero R, Miolo A, Di Marzo V.
Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential
use in companion animals.